Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
New technique could help when cardiologists repair 2 leaky heart valves at once
Performing M-TEER and T-TEER on the same patient using a single guide catheter appears to be both safe and effective. Researchers shared their experience with this approach in Circulation: Cardiovascular Interventions.
‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

FDA announces recall of 25,000 catheters after 167 complaints, 8 injuries

Parts of the device can move or become loose during procedures, the FDA warned.

PCI improves health of late-presenting STEMI patients

Moving forward with PCI can make a massive difference for STEMI patients, even 48 hours after symptoms first began.

Medtronic recalls embolization devices after 2 deaths, 10 serious injuries

Nearly 9,000 devices distributed in 2019 and 2020 are included in this Class 1 recall.

Florida cardiologist pays $6.75M to resolve fraud allegations

The physician and his practice also had to sign into a “multi-year integrity agreement” that includes specific training and reporting requirements.

Biotronik introduces new reinforced introducer sheaths to U.S., overseas markets

The new solutions were designed to help users during diagnostic, interventional and endovascular procedures.

Dual-layered stents are safe to use for carotid artery stenting, new 12-month study confirms

It was important for researchers to confirm these stents didn't increase a patient's long-term risk of adverse events.

'No-touch' vein harvesting technique boosts CABG outcomes

Experts think these new findings could ramp up the development of optimal revascularization strategies.

FDA approves new solution for preserving hearts before transplantation

The system preserves hearts that can’t be procured or transplanted right away due to a limited availability of storage space.

Interventional Cardiology

FDA clears TAVR guidewire built with BASILICA in mind

New technique could help when cardiologists repair 2 leaky heart valves at once

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

New physician Medicare payments for the Agent drug-coated balloon set for 2027